CARM: Carisma Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 67.71
Enterprise Value ($M) -9.89
Book Value ($M) 26.53
Book Value / Share 0.64
Price / Book 2.55
NCAV ($M) 17.45
NCAV / Share 0.42
Price / NCAV 3.88

Profitability (mra)
Return on Invested Capital (ROIC) -2.93
Return on Assets (ROA) -0.56
Return on Equity (ROE) -1.01

Liquidity (mrq)
Quick Ratio 5.06
Current Ratio 5.06

Balance Sheet (mrq) ($M)
Current Assets 80.47
Assets 89.55
Liabilities 63.02
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 14.92
Operating Income -88.73
Net Income -86.88
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -81.18
Cash from Investing 72.41
Cash from Financing 62.18

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-13 13G AbbVie Biotechnology Ltd 6.80
03-07 13D/A HealthCap VII, L.P. 8.40 0.00
02-13 13G/A Vanguard Group Inc 3.89
02-02 13G/A Longview Innovation Corp. 6.70 -6.29
01-26 13D/A Trustees Of The University Of Pennsylvania 3.10 -42.64

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 12,604 40,475 31.14
2024-04-25 25,199 91,213 27.63
2024-04-24 7,197 36,728 19.60
2024-04-23 21,413 25,482 84.03
2024-04-22 33,989 35,362 96.12

(click for more detail)

Similar Companies
BTMD – biote Corp. CADL – Candel Therapeutics, Inc.
CARA – Cara Therapeutics, Inc. CGTX – Cognition Therapeutics, Inc.
CHRS – Coherus BioSciences, Inc.


Financial data and stock pages provided by
Fintel.io